Delcath Systems Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Delcath Systems Inc's ROI in the second quarter of 2026?
Delcath Systems Inc achieved a return on average invested assets (ROI) of 0.46 % in its second quarter of 2026, this is above DCTH's average return on investment of -535.55%.
Delcath Systems Inc invested over the 12 months ending in its second quarter of 2026 $117 million

ROI fell compared to the first quarter of 2026, despite the net income growth of % from the first quarter of 2026.

Within the Healthcare sector 184 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2420 to 2433.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	74.74 %	148.02 %	245.29 %	408.46 %	172.4 %
Y / Y Net Income Change TTM	-76.16 %	-	-	-	-
Investment (TTM) in Millions	124	114	113	116	107
Return On Investment (TTM)	0.46 %	0.5 %	2.58 %	1.28 %	3.34 %
DCTH's Overall Ranking	# 2433	# 2420	# 2474	# 935	#
Seq. Investment Change TTM	3.82 %	7.68 %	11.55 %	40.12 %	47.36 %
Seq. Net Income Change TTM	-5.17 %	-79.22 %	125.38 %	-46.33 %	-
Net Income (TTM) in Millions	1	1	3	1	2

DCTH Company Profile >> Back to DCTH Roi Comparisons >> See Annual DCTH Return On Investment

Return On Investment DCTH's Ranking
Within:	No.
Industry	# 63
Sector	# 185
Overall	# 2433

Return On Investment Statistics
High	Average	Low
3.29 %	-535.55 %	-17203.81 %
		(Dec 31 2017)

News about Delcath Systems Inc Return on Investment ROI

Delcath Systems Strengthens Leadership with Appointment of Martha S. Rook as Chief Operating Officer

March 18, 2024

Delcath Systems Announces Martha S. Rook as New Chief Operating Officer
NEW YORK, March 18, 2024 - Delcath Systems, Inc., a leading interventional oncology company specializing in the treatment of primary and metastatic cancers of the liver, has recently appointed Martha S. Rook as its new Chief Operating Officer (COO). This strategic move is expected to bolster Delcath s operations and provide further momentum for the company as it continues to advance innovative liver cancer treatments.
Martha S. Rook brings a wealth of experience to Delcath Systems, with an impressive track record in the healthcare and pharmaceutical industries. She has held numerous leadership positions, most recently serving as the Vice President of Operations at a prominent oncology therapeutics company. Rook s expertise lies in operational excellence, streamlining processes, and driving business growth. By leveraging her extensive skill set, Delcath aims to enhance its operational efficiency and overall performance.

Financial Statements
Delcath Systems Inc's II. Quarter Investments	$ 124 Millions	DCTH's Balance sheet
Delcath Systems Inc's II. Quarter Income	$ 3 Millions	Quarterly DCTH's Income Statement
DCTH's Income by Division		See DCTH's Income by Division

DCTH Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	112	70	22	3	27
Y / Y Investment Growth	60.9 %	213.61 %	608.83 %	-88.4 %	11.65 %
Net Income in Millions	3	-26	-48	-37	-26
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	2.41 %	-37.96 %	-215.1 %	-1167.51 %	-95.13 %

Annual Roi Comment

In the fiscal year 2025 ROI improved to 2.41 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DCTH's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DCTH's Competitors
Subscribers only: Roi for Delcath Systems Inc's Suppliers
Subscribers only: Return On Investment for DCTH's Customers

Other Ratios
DCTH's Roa	DCTH's Inventory Turnover Ratio	DCTH's Growth Rates	DCTH's Dividend Statistics
	DCTH's Profitability Ratios	DCTH's Asset Turnover Ratio	DCTH's Dividend Growth
DCTH's Roe	DCTH's Valuation Ratios	DCTH's Financial Strength Ratios	DCTH's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector	ROI
Waters Corporation	1.20 %
Surgery Partners Inc	1.02 %
Warby Parker Inc	0.98 %
Staar Surgical Co	0.98 %
Biomarin Pharmaceutical Inc	0.91 %
Icu Medical Inc	0.87 %
Radnet Inc	0.45 %
Delcath Systems Inc	0.45 %
Champions Oncology Inc	0.18 %
Talkspace Inc	0.16 %
Denali Therapeutics Inc	0.09 %

Date modified: 2026-09-08T17:23:35+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.